NFA
TCRT icon

Nationwide Fund Advisors’s Alaunos Therapeutics TCRT Stock Holding History

Nationwide Fund Advisors’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-474
Closed -$437K – 1860
2017
Q3 		$437K Sell
474
-11
-2% -$9.77K ﹤0.01% 2252
2017
Q2 		$453K Buy
485
+14
+3% +$13.7K ﹤0.01% 2241
2017
Q1 		$448K Sell
471
-30
-6% -$27.9K ﹤0.01% 2213
2016
Q4 		$402K Sell
501
-28
-5% -$25.2K ﹤0.01% 2292
2016
Q3 		$447K Hold
529
– – ﹤0.01% 2229
2016
Q2 		$436K Buy
529
+39
+8% +$42.5K ﹤0.01% 2221
2016
Q1 		$562K Sell
490
-15
-3% -$15.4K ﹤0.01% 2032
2015
Q4 		$630K Buy
505
+10
+2% +$16.5K ﹤0.01% 1987
2015
Q3 		$669K Hold
495
– – ﹤0.01% 1937
2015
Q2 		$892K Buy
495
+52
+12% +$80.7K ﹤0.01% 1928
2015
Q1 		$716K Buy
443
+30
+7% +$44.5K ﹤0.01% 2067
2014
Q4 		$314K Sell
413
-3
-0.7% -$1.59K ﹤0.01% 2435
2014
Q3 		$165K Sell
416
-8
-2% -$3.86K ﹤0.01% 2790
2014
Q2 		$256K Buy
424
+12
+3% +$6.68K ﹤0.01% 2627
2014
Q1 		$283K Hold
412
– – ﹤0.01% 2331
2013
Q4 		$268K Buy
412
+58
+16% +$34.5K ﹤0.01% 2544
2013
Q3 		$210K Buy
354
+12
+4% +$5.41K ﹤0.01% 2631
2013
Q2 		$108K Buy
+342
New +$95K ﹤0.01% 2775

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nationwide Fund Advisors's TCRT Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Alaunos Therapeutics (TCRT) in Q4 2017, closing a stake of 474 shares — an estimated $437K sold.

Nationwide Fund Advisors first reported a position in TCRT in Q2 2013 and held it in 18 quarters. The position peaked at $892K in Q2 2015. 128 funds tracked by Wall St. Rank hold TCRT as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Alaunos Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 474 Alaunos Therapeutics shares in Q4 2017, an estimated $437K.
  • Nationwide Fund Advisors first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Alaunos Therapeutics position peaked at $892K in Q2 2015.
  • 128 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.